selected publications academic article Onset and progression of de novo donor-specific anti-human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction. Transplant Infectious Disease. 17:848-858. 2015 Impact of IgM and IgG3 anti-HLA alloantibodies in primary renal allograft recipients. Transplantation. 97:494-501. 2014 Changes in successive measures of de novo donor-specific anti-human leukocyte antigen antibodies intensity and the development of allograft dysfunction. Transplantation. 98:1097-1104. 2014 Improved Long-Term Survival in Kidney Transplant Recipients with Donor-Specific HLA Antibodies After Mycophenolic Acid Escalation. Clinical transplants. 137-142. 2014 Higher risk of kidney graft failure in the presence of anti-angiotensin II Type-1 receptor antibodies. American Journal of Transplantation. 13:2577-2589. 2013 Trends and characteristics in early glomerular filtration rate decline after posttransplantation alloantibody appearance. Transplantation. 96:919-925. 2013 The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes. Transplantation. 95:1113-1119. 2013 Incidence and impact of de Novo donor-specific alloantibody in primary renal allografts. Transplantation. 95:410-417. 2013 Novel biomarker combination predicts long-term allograft outcome.. Clinical transplants. 319-324. 2013 A report of the epidemiology of de novo donor-specific anti-HLA antibodies (DSA) in 'low-risk' renal transplant recipients.. Clinical transplants. 337-340. 2011 Erratum: Beyond histology: Lowering human leukocyte antigen antibody to improve renal allograft survival in acute rejection (Transplantation (2010) 89 (962)). Transplantation. 90:103. 2010 Beyond histology: Lowering human leukocyte antigen antibody to improve renal allograft survival in acute rejection. Transplantation. 89:962-967. 2010 Delayed skin allograft rejection following matrix membrane pretreatment. Journal of Plastic, Reconstructive and Aesthetic Surgery. 62:520-525. 2009 Organ procurement and transplantation network/united network for organ sharing histocompatibility committee collaborative study to evaluate prediction of crossmatch results in highly sensitized patients. Transplantation. 87:557-562. 2009 Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study. American Journal of Transplantation. 7:864-871. 2007 Analysis of HLA class I specific antibodies in patients with failed allografts. Transplantation. 83:54-61. 2007 Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.. Clinical transplants. 241-253. 2006 Development of nondonor-specific HLA-DR antibodies in allograft recipients is associated with shared epitopes with mismatched donor DR antigens. American Journal of Transplantation. 6:2947-2954. 2006 Longitudinal testing of 266 renal allograft patients for HLA and MICA antibodies: Greenville experience.. Clinical transplants. 265-290. 2006 The current status of xenotransplantation.. Current Surgery. 62:481-488. 2005 HLA matching and the united network for organ sharing allocation system: Impact of HLA matching on African-American recipients of cadaveric kidney transplants. Transplantation. 74:1634-1636. 2002 Haploidentical transplantation. Importance of histocompatibility testing and chimerism studies in allogeneic bone marrow/stem cell transplantation.. Journal of Infusion Nursing. 24:311-318. 2001 Use of allogeneic bone marrow labeled with neomycin resistance gene to examine bone marrow-derived chimerism in experimental organ transplantation. Cell Transplantation. 6:369-376. 1997 A gene transfer method for the study of chimerism derived from donor bone marrow in organ transplant recipients. Transplantation Proceedings. 27:158-159. 1995 Requirement for DR sharing in stable kidney allograft tolerance induced by donor bone marrow in rhesus monkeys. Transplantation Proceedings. 27:166-168. 1995
research overview Clinical Interests Histocompatibility testing and transplantation Research Interests Transplant immunobiology Post-transplant monitoring Donor-specific hyporesponsiveness Cytokine gene polymorphisms Xenotransplantation HLA and disease associations
